PUBLISHED: 2 Perhaps 2025 at 03: 30
A patient with multiple myeloma ( MM), a type of cancer, was given the opportunity to receive their first stem cell transplant. Rajavithi Hospital has accomplished this milestone in its efforts to develop life-saving medical technologies.
A multidisciplinary medical team at Rajavithi Hospital recently performed a haematopoietic stem cell transplantation ( HSCT) on a 60-year-old patient with MM, according to Dr. Jinda Rojanamatin, director of Rajavithi Hospital.
According to Dr. Jinda, the individual complained of serious spine pain, which led to the analysis of MM, a bone marrow cancer.
Chemotherapy, which gave a very good partial response (VGPR ), was used to begin the medical team’s treatment. The crew then moved on to more advanced treatment that involved stem cell series, harvesting 11.21 million cells per kilogram from the individual.
The client received an homologous haematopoietic stem cell transplantation on February 16 after receiving the collected healthy tissues.
Within nine times, the patient showed clear signs of recovery without any issues, and she responded well to the care, according to the doctor.
High protein levels in the blood are frequently the result of tooth pain, injuries, kidney malfunction, and elevated potassium levels, which is the result of an unusual development of blood cells.
” Haematopoietic stem cell transplantation not only increases the chances of survival but also provides a more effective treatment outcome,” said Dr. Jinda.
In homologous stem cell transplants, a patient replaces damaged tooth blood with their own blood stem cells. This approach lowers the chance of rejection and other problems by preventing compatibility issues that are frequently associated with donor implants.
The success of this stem cell transplantation, according to Dr. Jinda, represents a significant improvement in the patient’s ability to provide cutting-edge care to patients who have difficult conditions.